These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33574718)

  • 1. Self-Stigma and Treatment Effectiveness in Patients with SSRI Non-Responsive Obsessive-Compulsive Disorder.
    Ociskova M; Prasko J; Vanek J; Holubova M; Hodny F; Latalova K; Kantor K; Nesnidal V
    Psychol Res Behav Manag; 2021; 14():85-97. PubMed ID: 33574718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early life experiences and adult attachment in obsessive-compulsive disorder. Part 1: Relationships between demographic, clinical, and psychological factors in pharmacoresistant OCD.
    Hodny F; Ociskova M; Prasko J; Houdkova M; Vanek J; Sollar T; Visnovsky J; Slepecky M; Nesnídal V; Latalova K; Kolek A; Bocek J
    Neuro Endocrinol Lett; 2022 Dec; 43(6):333-344. PubMed ID: 36716391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis.
    Ociskova M; Prasko J; Vrbova K; Kasalova P; Holubova M; Grambal A; Machu K
    Neuropsychiatr Dis Treat; 2018; 14():383-392. PubMed ID: 29416340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of Gamma Knife anterior capsulotomy for refractory obsessive-compulsive disorder: results in a series of 10 consecutive patients.
    Spatola G; Martinez-Alvarez R; Martínez-Moreno N; Rey G; Linera J; Rios-Lago M; Sanz M; Gutiérrez J; Vidal P; Richieri R; Régis J
    J Neurosurg; 2018 Sep; 131(2):376-383. PubMed ID: 30215566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder.
    Prasko J; Raszka M; Adamcova K; Grambal A; Koprivova J; Kudrnovská H; Latalova K; Vyskocilová J
    Neuro Endocrinol Lett; 2009; 30(5):615-23. PubMed ID: 20035255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-stigma, severity of psychopatology, dissociation, parental style and comorbid personality disorder in patient with neurotic spectrum disorders Part 2: Therapeutic efficacy of intensive psychotherapeutic inpatients program.
    Holubova M; Prasko J; Hodny F; Vanek J; Slepecky M; Nesnidal V
    Neuro Endocrinol Lett; 2021 Jul; 42(3):185-199. PubMed ID: 34279862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early life experiences and adult attachment in obsessive-compulsive disorder. Part 2: Therapeutic effectiveness of combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients.
    Hodny F; Ociskova M; Prasko J; Vanek J; Visnovsky J; Sollar T; Slepecky M; Nesnídal V; Kolek A
    Neuro Endocrinol Lett; 2022 Dec; 43(6):345-358. PubMed ID: 36716392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
    Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
    Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder.
    Prasko J; Ociskova M; Grambal A; Sigmundova Z; Kasalova P; Marackova M; Holubova M; Vrbova K; Latalova K; Slepecky M
    Neuropsychiatr Dis Treat; 2016; 12():2539-2552. PubMed ID: 27785031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does time-intensive ERP attenuate the negative impact of comorbid personality disorders on the outcome of treatment-resistant OCD?
    Dèttore D; Pozza A; Coradeschi D
    J Behav Ther Exp Psychiatry; 2013 Dec; 44(4):411-7. PubMed ID: 23770674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients.
    Ociskova M; Prasko J; Latalova K; Kamaradova D; Grambal A
    Neuropsychiatr Dis Treat; 2016; 12():1539-51. PubMed ID: 27445474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the Thai version of the Yale-Brown Obsessive Compulsive Scale - Second Edition in clinical samples.
    Hiranyatheb T; Saipanish R; Lotrakul M
    Neuropsychiatr Dis Treat; 2014; 10():471-7. PubMed ID: 24648741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Thai self-report version of the Yale-Brown Obsessive-Compulsive Scale-Second Edition.
    Hiranyatheb T; Saipanish R; Lotrakul M; Prasertchai R; Ketkaew W; Jullagate S; Udomsubpayakul U; Kusalaruk P
    Neuropsychiatr Dis Treat; 2015; 11():2817-24. PubMed ID: 26604766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of cognitive behavioral group psychotherapy for obsessive-compulsive disorder.
    Safak Y; Karadere ME; Ozdel K; Ozcan T; Türkçapar MH; Kuru E; Yücens B
    Turk Psikiyatri Derg; 2014; 25(4):225-33. PubMed ID: 25487620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
    Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioral therapy in pharmacoresistant obsessive-compulsive disorder.
    Vyskocilova J; Prasko J; Sipek J
    Neuropsychiatr Dis Treat; 2016; 12():625-39. PubMed ID: 27042074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of cognitive function in treatment-refractory obsessive-compulsive disorder treated with capsulotomy.
    Gong F; Li P; Li B; Zhang S; Zhang X; Yang S; Liu H; Wang W
    J Neurosurg; 2018 Feb; 128(2):583-595. PubMed ID: 28338440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition.
    Zhang CC; Gong H; Zhang Y; Jin H; Yang Y; Li B; Li Y; Luo X; Liu W; Fang F; Li B; Sun B; Fletcher T; La Buissonnière-Ariza V; Goodman WK; Storch EA
    Braz J Psychiatry; 2019; 41(6):494-498. PubMed ID: 30785537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the COVID-19 Pandemic on Obsessive-Compulsive Symptoms Among University Students: Prospective Cohort Survey Study.
    Ji G; Wei W; Yue KC; Li H; Shi LJ; Ma JD; He CY; Zhou SS; Zhao Z; Lou T; Cheng J; Yang SC; Hu XZ
    J Med Internet Res; 2020 Sep; 22(9):e21915. PubMed ID: 32931444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.
    Bejerot S; Edman G; Anckarsäter H; Berglund G; Gillberg C; Hofvander B; Humble MB; Mörtberg E; Råstam M; Ståhlberg O; Frisén L
    Nord J Psychiatry; 2014 Nov; 68(8):549-59. PubMed ID: 24568661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.